BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20030653)

  • 21. [Comparison of full-field digital mammography and magnetic resonance imaging for breast disease diagnosis].
    Wang Q; Hu GD; Kuang J; Li JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):292-4. PubMed ID: 19246303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
    Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
    Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamic enhanced MRI and chemosensitivity in breast cancer].
    Nagashima T; Sakakibara M; Miyazaki M; Kazama T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():530-4. PubMed ID: 17682206
    [No Abstract]   [Full Text] [Related]  

  • 26. [Computed tomography laser mammography].
    Bílková A; Janík V; Svoboda B
    Cas Lek Cesk; 2010; 149(2):61-5. PubMed ID: 20662467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis in breast cancer: how should we measure this? (Review).
    Pollitt MJ; Hanby AM; Horgan K; Murphy CE; Jones PF; Speirs V
    Oncol Rep; 2005 May; 13(5):931-6. PubMed ID: 15809760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of vascularisation in invasive breast carcinoma.
    Vermeulen PB; Fox SB; Dirix LY; Colpaert C; Van Marck EA
    Eur J Cancer; 2002 Sep; 38(14):1951-2. PubMed ID: 12204679
    [No Abstract]   [Full Text] [Related]  

  • 29. Shining light on breast tumors.
    Vastag B
    J Natl Cancer Inst; 1999 Dec; 91(24):2072-3. PubMed ID: 10601373
    [No Abstract]   [Full Text] [Related]  

  • 30. Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect.
    Beranek JT
    Br J Cancer; 1989 Jul; 60(1):149. PubMed ID: 2478179
    [No Abstract]   [Full Text] [Related]  

  • 31. Breast cancer therapy.
    Benson JR; Osborne MP
    Lancet; 1998 Jan; 351(9096):145. PubMed ID: 9439526
    [No Abstract]   [Full Text] [Related]  

  • 32. Breast cancer angio-histogenesis: through a narrow window.
    Page DL; Dupont WD
    J Natl Cancer Inst; 1992 Dec; 84(24):1850-1. PubMed ID: 1281235
    [No Abstract]   [Full Text] [Related]  

  • 33. Very Large Malignant Tumour of Breast: Removal: Recovery.
    Pratt JJ
    Ind Med Gaz; 1890 Jul; 25(7):209. PubMed ID: 29000544
    [No Abstract]   [Full Text] [Related]  

  • 34. New marker related to cancer neoangiogenesis: RGS5.
    Neagu M; Albulescu R; Tanase C
    Biomark Med; 2012 Apr; 6(2):197-8. PubMed ID: 22550752
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions.
    Froeling V; Diekmann F; Renz DM; Fallenberg EM; Steffen IG; Diekmann S; Lawaczeck R; Schmitzberger FF
    Eur Radiol; 2013 Jun; 23(6):1528-36. PubMed ID: 23306708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Standing Scirrhous Breast Carcinoma en Cuirasse.
    Lacout A; Marcy PY; Lesec G
    Breast Care (Basel); 2010; 5(5):327-329. PubMed ID: 21779215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exception to tumour neoangiogenesis in a malignant breast-lesion.
    Baltzer PA; Benndorf M; Gajda M; Kaiser WA
    Breast J; 2010; 16(2):197-8. PubMed ID: 20030653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximum intensity projection analysis in magnetic resonance of the breast.
    Carriero A; Di Credico A; Mansour M; Bonomo L
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):77-81. PubMed ID: 12585659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.